Clinical Trial

Blood Collection Biorepository for Liver Disease Research

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-01-18; most recent amendment 2025-08-20.
Trial Details
NCT Number NCT03025074
Lead Sponsor State University of New York at Buffalo
Conditions Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate
Enrollment 1,000 participants
Start Date 2013-07
Primary Completion 2099-12 (estimated)
Study Completion 2099-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-27